Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1360385

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1360385

Global Tissue Engineering Market Size, Share, Growth Analysis, By Material(Synthetic Material, and Biologically Derived Material), By Application(Cord blood & Cell Banking, Gynecology) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Tissue Engineering Market size was valued at USD 13 Billion in 2021 and is poised to grow from USD 14.39 Billion in 2022 to USD 32.45 Billion by 2030, at a CAGR of 10.7% during the forecast period (2023-2030).

The global tissue engineering market is experiencing significant growth due to advancements in regenerative medicine and organ transplantation. This innovative field involves creating functional tissues using biocompatible materials, cells, and biochemical factors. With increasing demand for organ transplants and the rising prevalence of chronic diseases, the market is expanding. Companies are investing in research to develop effective tissue engineering solutions, including scaffolds, biomaterials, and cell therapies, to address the growing medical needs globally.

Top-down and bottom-up approaches were used to estimate and validate the size of tissue engineering and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Drivers

The uptick in chronic ailment occurrences, encompassing cardiovascular issues, orthopedic ailments, and organ insufficiencies, has significantly propelled the tissue engineering sector. Tissue engineering presents promising remedies for tissue and organ reconstruction, providing enhanced therapeutic alternatives for individuals grappling with persistent health conditions.

Restraints

Privacy and security issues emerge with the accumulation and examination of social media data, giving rise to apprehensions about data protection. The necessity for adherence to more stringent regulations and compliance protocols could present difficulties for providers of social media analytics in their task of managing and safeguarding user data.

Market Trends

The global tissue engineering industry encounters obstacles in terms of regulations encompassing the safety, effectiveness, and ethical considerations linked to the application of bioengineered tissues and cells. Stringent regulatory frameworks and extensive endorsement procedures have the potential to hinder the advancement of the market, thereby restricting the accessibility of tissue engineering offerings and treatments.

Product Code: SQMIG35H2087

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Tissue Engineering Market by Material
  • Market Overview
  • Synthetic Material
  • and Biologically Derived Material

Global Tissue Engineering Market by Application

  • Market Overview
  • Cord blood & Cell Banking
  • Gynecology
  • Cancer
  • Skin & Integumentary
  • Dental
  • Cardiology & Vascular
  • and Others
  • Global Tissue Engineering Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Organogenesis Holdings Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Acelity L.P. Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Integra LifeSciences Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Zimmer Biomet Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Wright Medical Group N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Cook Medical Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • MiMedx Group, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Osiris Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Tissue Regenix Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • NuVasive, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Cellular Dynamics International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Vericel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • RepliCel Life Sciences Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Organovo Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • AlloSource (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!